Northern Trust’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13M Sell
1,610,675
-97,952
-6% -$792K ﹤0.01% 1913
2025
Q1
$14.3M Sell
1,708,627
-68,656
-4% -$575K ﹤0.01% 1833
2024
Q4
$14.1M Buy
1,777,283
+156,699
+10% +$1.24M ﹤0.01% 1926
2024
Q3
$13.5M Buy
1,620,584
+367,732
+29% +$3.06M ﹤0.01% 1883
2024
Q2
$7.96M Sell
1,252,852
-14,332
-1% -$91K ﹤0.01% 2122
2024
Q1
$7.68M Sell
1,267,184
-53,451
-4% -$324K ﹤0.01% 2215
2023
Q4
$8.02M Buy
1,320,635
+113,872
+9% +$691K ﹤0.01% 2215
2023
Q3
$5.09M Buy
1,206,763
+16,935
+1% +$71.5K ﹤0.01% 2432
2023
Q2
$3.69M Buy
1,189,828
+157,943
+15% +$490K ﹤0.01% 2668
2023
Q1
$1.43M Buy
1,031,885
+4,768
+0.5% +$6.63K ﹤0.01% 3089
2022
Q4
$2.04M Sell
1,027,117
-15,432
-1% -$30.7K ﹤0.01% 2982
2022
Q3
$2.11M Sell
1,042,549
-7,839
-0.7% -$15.8K ﹤0.01% 2990
2022
Q2
$3.34M Buy
1,050,388
+24,593
+2% +$78.2K ﹤0.01% 2766
2022
Q1
$4.28M Sell
1,025,795
-70,072
-6% -$292K ﹤0.01% 2670
2021
Q4
$5.25M Sell
1,095,867
-51,375
-4% -$246K ﹤0.01% 2649
2021
Q3
$6.13M Sell
1,147,242
-49,738
-4% -$266K ﹤0.01% 2603
2021
Q2
$6.13M Sell
1,196,980
-78,326
-6% -$401K ﹤0.01% 2723
2021
Q1
$8.58M Sell
1,275,306
-121,155
-9% -$815K ﹤0.01% 2390
2020
Q4
$6.38M Sell
1,396,461
-53,348
-4% -$244K ﹤0.01% 2535
2020
Q3
$5.63M Sell
1,449,809
-71,551
-5% -$278K ﹤0.01% 2463
2020
Q2
$7.24M Sell
1,521,360
-33,047
-2% -$157K ﹤0.01% 2297
2020
Q1
$5.41M Buy
1,554,407
+16,083
+1% +$56K ﹤0.01% 2262
2019
Q4
$7.42M Buy
1,538,324
+185,740
+14% +$895K ﹤0.01% 2370
2019
Q3
$3.92M Buy
1,352,584
+151,846
+13% +$440K ﹤0.01% 2683
2019
Q2
$8.61M Buy
1,200,738
+14,961
+1% +$107K ﹤0.01% 2242
2019
Q1
$16.8M Sell
1,185,777
-10,938
-0.9% -$155K ﹤0.01% 1834
2018
Q4
$16.2M Sell
1,196,715
-20,034
-2% -$271K ﹤0.01% 1752
2018
Q3
$27M Buy
1,216,749
+44,457
+4% +$987K 0.01% 1536
2018
Q2
$19.2M Buy
+1,172,292
New +$19.2M ﹤0.01% 1808